465 related articles for article (PubMed ID: 18683748)
41. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
42. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
43. Polymorphism of the interleukin-10 gene in polycystic ovary syndrome.
Karadeniz M; Erdogan M; Zengi A; Tamsel S; Berdeli A; Saygili F; Yilmaz C
Int J Immunogenet; 2008 Apr; 35(2):119-23. PubMed ID: 18218037
[TBL] [Abstract][Full Text] [Related]
44. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
45. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
46. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
[TBL] [Abstract][Full Text] [Related]
47. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
Song J; Shen H; Li J; Huang Z; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
[TBL] [Abstract][Full Text] [Related]
48. No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia.
Marioli DJ; Koika V; Adonakis GL; Saltamavros AD; Karela A; Armeni AK; Tsapanos VS; Decavalas GO; Georgopoulos NA
Arch Gynecol Obstet; 2010 Jun; 281(6):1045-9. PubMed ID: 20012307
[TBL] [Abstract][Full Text] [Related]
49. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women.
Cui L; Zhao H; Zhang B; Qu Z; Liu J; Liang X; Zhao X; Zhao J; Sun Y; Wang P; Li T; Shi Y; Chen ZJ
Hum Reprod; 2013 Feb; 28(2):538-44. PubMed ID: 23208300
[TBL] [Abstract][Full Text] [Related]
50. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
51. Four polymorphisms of the CAPN 10 gene and their relationship to polycystic ovary syndrome susceptibility: a meta-analysis.
Huang M; Xiao J; Zhao X; Liu C; Chen Q
Clin Endocrinol (Oxf); 2012 Mar; 76(3):431-8. PubMed ID: 21906115
[TBL] [Abstract][Full Text] [Related]
52. Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome.
Sóter MO; Ferreira CN; Sales MF; Candido AL; Reis FM; Milagres KS; Ronda C; Silva IO; Sousa MO; Gomes KB
Cytokine; 2015 Dec; 76(2):227-235. PubMed ID: 26141422
[TBL] [Abstract][Full Text] [Related]
53. Polymorphisms of vascular cell adhesion molecule1 (VCAM1) in polycystic ovary syndrome determined by quantitative real-time polymerase chain reaction and melting curve analysis.
Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Gedikbaşı A; Çil E; Karadağ B; Uysal M
Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):174-8. PubMed ID: 22137570
[TBL] [Abstract][Full Text] [Related]
54. Association of the luteinizing hormone/choriogonadotropin receptor gene polymorphism with polycystic ovary syndrome.
Bassiouny YA; Rabie WA; Hassan AA; Darwish RK
Gynecol Endocrinol; 2014 Jun; 30(6):428-30. PubMed ID: 24592983
[TBL] [Abstract][Full Text] [Related]
55. [Association between single nucleotide polymorphism of rs2252673 of INSR gene and polycystic ovarian syndrome].
Du J; Wang Z; Zhang J; Jia L; Zhang F; Shi Y; Chen Z
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):919-24. PubMed ID: 25608993
[TBL] [Abstract][Full Text] [Related]
56. Specific haplotypes of the CALPAIN-5 gene are associated with polycystic ovary syndrome.
González A; Sáez ME; Aragón MJ; Galán JJ; Vettori P; Molina L; Rubio C; Real LM; Ruiz A; Ramírez-Lorca R
Hum Reprod; 2006 Apr; 21(4):943-51. PubMed ID: 16396936
[TBL] [Abstract][Full Text] [Related]
57. Calpain 10 gene single-nucleotide 44 polymorphism may have an influence on clinical and metabolic features in patients with polycystic ovary syndrome.
Yilmaz M; Yurtçu E; Demirci H; Ergün MA; Ersoy R; Karakoç A; Yetkin I; Cakir N; Ayvaz G; Arslan M
J Endocrinol Invest; 2009 Jan; 32(1):13-7. PubMed ID: 19337008
[TBL] [Abstract][Full Text] [Related]
58. Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome.
Thangavelu M; Godla UR; Paul Solomon FD; Maddaly R
J Genet; 2017 Mar; 96(1):87-96. PubMed ID: 28360393
[TBL] [Abstract][Full Text] [Related]
59. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B
Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959
[TBL] [Abstract][Full Text] [Related]
60. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
Chen Y; Wang XJ; Jin HL; Jin L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
